Schizophrenia: an integrated sociodevelopmental-cognitive model

[1]  S. Kapur,et al.  Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms , 2014, Biological Psychiatry.

[2]  T. Vos,et al.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.

[3]  Tyrone D. Cannon,et al.  Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study , 2013, Biological Psychiatry.

[4]  A. Egerton,et al.  Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort , 2013, Biological Psychiatry.

[5]  R. Kahn,et al.  Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. , 2013, Schizophrenia bulletin.

[6]  A. Grace,et al.  Peripubertal Diazepam Administration Prevents the Emergence of Dopamine System Hyperresponsivity in the MAM Developmental Disruption Model of Schizophrenia , 2013, Neuropsychopharmacology.

[7]  E. Bramon,et al.  Striatal dopamine transporter availability in drug-naive patients with schizophrenia: a case-control SPECT study with [(99m)Tc]-TRODAT-1 and a meta-analysis. , 2013, Schizophrenia bulletin.

[8]  F. Turkheimer,et al.  Nature or Nurture? Determining the Heritability of Human Striatal Dopamine Function: an [18F]-DOPA PET Study , 2013, Neuropsychopharmacology.

[9]  M. Geyer,et al.  Sensory and sensorimotor gating in adult attention-deficit/hyperactivity disorder (ADHD) , 2013, Psychiatry Research.

[10]  R. Murray,et al.  The Myth of Schizophrenia as a Progressive Brain Disease , 2012, Schizophrenia bulletin.

[11]  L. Kegeles,et al.  Striatal Dopamine Release in Schizophrenia Comorbid with Substance Dependence , 2012, Molecular Psychiatry.

[12]  Peter R Luijten,et al.  Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. , 2013, Schizophrenia bulletin.

[13]  R. Murray,et al.  Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users , 2012, Biological Psychiatry.

[14]  P. Balsam,et al.  Schizophrenia in translation: dissecting motivation in schizophrenia and rodents. , 2012, Schizophrenia bulletin.

[15]  D. Rujescu,et al.  Copy number variations in neurodevelopmental disorders , 2012, Progress in Neurobiology.

[16]  R. Romo,et al.  Dopaminergic activity coincides with stimulus detection by the frontal lobe , 2012, Neuroscience.

[17]  P. McGorry,et al.  Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies , 2012, Schizophrenia Research.

[18]  Mark Slifstein,et al.  The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.

[19]  John M. Davis,et al.  Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis , 2012, The Lancet.

[20]  Daniel L. Koller,et al.  Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction , 2012, Molecular Psychiatry.

[21]  G. Lewis,et al.  Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies , 2012, Psychological Medicine.

[22]  J N Giedd,et al.  Neurodevelopmental model of schizophrenia: update 2012 , 2012, Molecular Psychiatry.

[23]  A. Harrington.  The fall of the schizophrenogenic mother , 2012, The Lancet.

[24]  J. Read,et al.  Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies , 2012, Schizophrenia bulletin.

[25]  Jens C. Pruessner,et al.  Increased Stress-Induced Dopamine Release in Psychosis , 2012, Biological Psychiatry.

[26]  E. Emamian.  AKT/GSK3 signaling pathway and schizophrenia , 2012, Front. Mol. Neurosci..

[27]  J. Feldon,et al.  Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models , 2012, Translational Psychiatry.

[28]  D. Weinberger,et al.  Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways , 2012, Molecular Psychiatry.

[29]  R. Murray,et al.  Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. , 2011, The American journal of psychiatry.

[30]  R. Romo,et al.  Dopamine neurons code subjective sensory experience and uncertainty of perceptual decisions , 2011, Proceedings of the National Academy of Sciences.

[31]  B. Trainor.  Stress responses and the mesolimbic dopamine system: Social contexts and sex differences , 2011, Hormones and Behavior.

[32]  Carlos S. Moreno,et al.  Relative Burden of Large CNVs on a Range of Neurodevelopmental Phenotypes , 2011, PLoS genetics.

[33]  C. Marsden,et al.  Influence of social isolation in the rat on serotonergic function and memory – Relevance to models of schizophrenia and the role  of 5-HT6 receptors , 2011, Neuropharmacology.

[34]  R. Murray,et al.  Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study , 2011, Molecular Psychiatry.

[35]  A. Grace,et al.  A Novel α5GABAAR-Positive Allosteric Modulator Reverses Hyperactivation of the Dopamine System in the MAM Model of Schizophrenia , 2011, Neuropsychopharmacology.

[36]  Jens C. Pruessner,et al.  City living and urban upbringing affect neural social stress processing in humans , 2011, Nature.

[37]  R. Murray,et al.  Functional magnetic resonance imaging investigation of the amphetamine sensitization model of schizophrenia in healthy male volunteers. , 2011, Archives of general psychiatry.

[38]  R. Murray,et al.  Striatal dopamine synthesis capacity in twins discordant for schizophrenia , 2011, Psychological Medicine.

[39]  A. Kakita,et al.  Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia , 2011, Molecular Psychiatry.

[40]  N. Craddock,et al.  Neurodevelopmental hypothesis of schizophrenia , 2011, The British journal of psychiatry : the journal of mental science.

[41]  R. Winkel.  Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis: Sibling Analysis and Proband Follow-up , 2011 .

[42]  Ronald Pierson,et al.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. , 2011, Archives of general psychiatry.

[43]  J. Lieberman,et al.  Presynaptic regulation of dopamine transmission in schizophrenia. , 2011, Schizophrenia bulletin.

[44]  Akira Wada,et al.  Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study , 2011, Medical Molecular Morphology.

[45]  A. Graff-Guerrero,et al.  Functional magnetic resonance imaging response to experimental pain in drug-free patients with schizophrenia , 2010, Psychiatry Research: Neuroimaging.

[46]  Clive H. Y. Wong,et al.  Autistic Disorders and Schizophrenia: Related or Remote? An Anatomical Likelihood Estimation , 2010, PloS one.

[47]  R. Chambers,et al.  Ventral and dorsal striatal dopamine efflux and behavior in rats with simple vs. co-morbid histories of cocaine sensitization and neonatal ventral hippocampal lesions , 2010, Psychopharmacology.

[48]  R. Murray,et al.  Migration, ethnicity, and psychosis: toward a sociodevelopmental model. , 2010, Schizophrenia bulletin.

[49]  Peilin Jia,et al.  Schizophrenia Gene Networks and Pathways and Their Applications for Novel Candidate Gene Selection , 2010, PloS one.

[50]  A. Aguilar-Valles,et al.  Prenatal Inflammation-Induced Hypoferremia Alters Dopamine Function in the Adult Offspring in Rat: Relevance for Schizophrenia , 2010, PloS one.

[51]  A. Heinz,et al.  Dopaminergic dysfunction in schizophrenia: salience attribution revisited. , 2010, Schizophrenia bulletin.

[52]  Ulrich Stephani,et al.  Genome-Wide Copy Number Variation in Epilepsy: Novel Susceptibility Loci in Idiopathic Generalized and Focal Epilepsies , 2010, PLoS genetics.

[53]  G. Murray.  The emerging biology of delusions , 2010, Psychological Medicine.

[54]  Eleanor H. Simpson,et al.  A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia , 2010, Neuron.

[55]  Alan S. Brown,et al.  Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. , 2010, The American journal of psychiatry.

[56]  A. Gruber,et al.  Knockdown of DISC1 by In Utero Gene Transfer Disturbs Postnatal Dopaminergic Maturation in the Frontal Cortex and Leads to Adult Behavioral Deficits , 2010, Neuron.

[57]  Richie Poulton,et al.  Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. , 2010, The American journal of psychiatry.

[58]  J. Feldon,et al.  A LONGITUDINAL EXAMINATION OF THE NEURODEVELOPMENTAL IMPACT OF PRENATAL IMMUNE ACTIVATION IN MICE REVEALS PRIMARY DEFECTS IN DOPAMINERGIC DEVELOPMENT RELEVANT TO SCHIZOPHRENIA , 2010, Schizophrenia Research.

[59]  H. Hakonarson,et al.  CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy , 2010, Molecular Psychiatry.

[60]  L. Weiss.  Autism genetics: emerging data from genome-wide copy-number and single nucleotide polymorphism scans , 2009, Expert review of molecular diagnostics.

[61]  Tyrone D. Cannon,et al.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. , 2009, Schizophrenia bulletin.

[62]  Akira Sawa,et al.  Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1–ErbB4 and DISC1 , 2009, Trends in Neurosciences.

[63]  Pall I. Olason,et al.  Common variants conferring risk of schizophrenia , 2009, Nature.

[64]  S. Kapur,et al.  Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. , 2009, Current pharmaceutical design.

[65]  F. Turkheimer,et al.  The effect of ageing on grey and white matter reductions in schizophrenia , 2009, Schizophrenia Research.

[66]  Mitul A. Mehta,et al.  The dopaminergic basis of human behaviors: A review of molecular imaging studies , 2009, Neuroscience & Biobehavioral Reviews.

[67]  E. Budygin,et al.  Increased phasic dopamine signaling in the mesolimbic pathway during social defeat in rats , 2009, Neuroscience.

[68]  S. Kapur,et al.  The dopamine hypothesis of schizophrenia: version III--the final common pathway. , 2009, Schizophrenia bulletin.

[69]  Robert Howard,et al.  The cognitive and affective structure of paranoid delusions: a transdiagnostic investigation of patients with schizophrenia spectrum disorders and depression. , 2009, Archives of general psychiatry.

[70]  Marie-Claude Asselin,et al.  Elevated striatal dopamine function linked to prodromal signs of schizophrenia. , 2009, Archives of general psychiatry.

[71]  ChrisD . Frith,et al.  Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia , 2009, Nature Reviews Neuroscience.

[72]  F. Turkheimer,et al.  Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging , 2008, Schizophrenia Research.

[73]  S Marenco,et al.  Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk , 2008, Molecular Psychiatry.

[74]  Robin M. Murray,et al.  Schizophrenia: From developmental deviance to dopamine dysregulation , 2008, European Neuropsychopharmacology.

[75]  E. Bullmore,et al.  The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. , 2008, The American journal of psychiatry.

[76]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[77]  D. Javitt,et al.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia , 2008, Trends in Neurosciences.

[78]  J. Os,et al.  Effects of acute metabolic stress on the dopaminergic and pituitary–adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls , 2008, Schizophrenia Research.

[79]  Michael E Talkowski,et al.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia. , 2008, Human molecular genetics.

[80]  P. McGuire,et al.  Functional neuroimaging in schizophrenia: diagnosis and drug discovery. , 2008, Trends in pharmacological sciences.

[81]  T. McGlashan,et al.  Striatal Dopamine Synthesis in First-degree Relatives of Patients with Schizophrenia , 2008, Biological Psychiatry.

[82]  K. Braun,et al.  Early stress and chronic methylphenidate cross‐sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens , 2007, Journal of neurochemistry.

[83]  E. Cantor-Graae,et al.  Hypothesis: social defeat is a risk factor for schizophrenia? , 2007, The British journal of psychiatry. Supplement.

[84]  R. Murray,et al.  Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. , 2007, The British journal of psychiatry. Supplement.

[85]  A. Grace,et al.  Aberrant Hippocampal Activity Underlies the Dopamine Dysregulation in an Animal Model of Schizophrenia , 2007, The Journal of Neuroscience.

[86]  J. Lieberman,et al.  Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia. , 2007, Schizophrenia bulletin.

[87]  H. Manji,et al.  Strain Differences in Lithium Attenuation of d-Amphetamine-Induced Hyperlocomotion: A Mouse Model for the Genetics of Clinical Response to Lithium , 2007, Neuropsychopharmacology.

[88]  Jonathan P Roiser,et al.  Cognitive heterogeneity in schizophrenia , 2007, Current opinion in psychiatry.

[89]  A. Dagher,et al.  Conditioned Dopamine Release in Humans: A Positron Emission Tomography [11C]Raclopride Study with Amphetamine , 2007, The Journal of Neuroscience.

[90]  D. Wong,et al.  Association of Amphetamine-Induced Striatal Dopamine Release and Cortisol Responses to Psychological Stress , 2007, Neuropsychopharmacology.

[91]  E. Kuipers,et al.  Implications for neurobiological research of cognitive models of psychosis: a theoretical paper , 2007, Psychological Medicine.

[92]  A. Minassian,et al.  Sensorimotor Gating Deficits in Adults with Autism , 2007, Biological Psychiatry.

[93]  Alain Dagher,et al.  Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. , 2006, Archives of general psychiatry.

[94]  John Suckling,et al.  Evidence that brain tissue volumes are associated with HVA reactivity to metabolic stress in schizophrenia , 2006, Schizophrenia Research.

[95]  Anthony A. Grace,et al.  A Neurobehavioral Systems Analysis of Adult Rats Exposed to Methylazoxymethanol Acetate on E17: Implications for the Neuropathology of Schizophrenia , 2006, Biological Psychiatry.

[96]  Mitul A Mehta,et al.  Is psychological stress in man associated with increased striatal dopamine levels?: A [11C]raclopride PET study , 2006, Synapse.

[97]  Christoph Schmitz,et al.  Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia , 2006, Schizophrenia Research.

[98]  T. Slotkin,et al.  Critical Prenatal and Postnatal Periods for Persistent Effects of Dexamethasone on Serotonergic and Dopaminergic Systems , 2006, Neuropsychopharmacology.

[99]  D. Wolpert,et al.  Evidence for sensory prediction deficits in schizophrenia. , 2005, The American journal of psychiatry.

[100]  E. Bramon,et al.  Dermatoglyphics and Schizophrenia: A meta-analysis and investigation of the impact of obstetric complications upon a–b ridge count , 2005, Schizophrenia Research.

[101]  J. van os,et al.  The incidence and outcome of subclinical psychotic experiences in the general population. , 2005, The British journal of clinical psychology.

[102]  J L Rapoport,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[103]  J. Koolhaas,et al.  A single social defeat induces short-lasting behavioral sensitization to amphetamine , 2005, Physiology & Behavior.

[104]  J. Os,et al.  Behavioural sensitization to daily life stress in psychosis , 2005, Psychological Medicine.

[105]  Lydia Krabbendam,et al.  Schizophrenia and urbanicity: a major environmental influence--conditional on genetic risk. , 2005, Schizophrenia bulletin.

[106]  E. Cantor-Graae,et al.  Schizophrenia and migration: a meta-analysis and review. , 2005, The American journal of psychiatry.

[107]  A. Mcbride,et al.  Stimulant psychosis: systematic review , 2004, British Journal of Psychiatry.

[108]  L. Siever,et al.  Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide , 2004, Biological Psychiatry.

[109]  T. Sotnikova,et al.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[110]  Jens C. Pruessner,et al.  Dopamine Release in Response to a Psychological Stress in Humans and Its Relationship to Early Life Maternal Care: A Positron Emission Tomography Study Using [11C]Raclopride , 2004, The Journal of Neuroscience.

[111]  R. Murray,et al.  Pathways to schizophrenia: the impact of environmental factors. , 2004, The international journal of neuropsychopharmacology.

[112]  Anissa Abi-Dargham,et al.  Do we still believe in the dopamine hypothesis? New data bring new evidence. , 2004, The international journal of neuropsychopharmacology.

[113]  C. Marsden,et al.  Influence of Postweaning Social Isolation in the Rat on Brain Development, Conditioned Behavior, and Neurotransmission , 2004, Neuroscience and Behavioral Physiology.

[114]  A. Grace,et al.  Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms. , 2004, Schizophrenia bulletin.

[115]  J. Karhu,et al.  Altered auditory processing in acutely psychotic never-medicated first-episode patients. , 2003, Brain research. Cognitive brain research.

[116]  B. El-Khodor,et al.  Differential vulnerability of male versus female rats to long-term effects of birth insult on brain catecholamine levels , 2003, Experimental Neurology.

[117]  Michael F Egan,et al.  Neonatal ventral hippocampal damage modifies serum corticosterone and dopamine release responses to acute footshock in adult Sprague‐Dawley rats , 2003, Synapse.

[118]  X. Zhang,et al.  Chronic neonatal isolation stress enhances cocaine-induced increases in ventral striatal dopamine levels in rat pups. , 2003, Brain research. Developmental brain research.

[119]  John Suckling,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[120]  B. El-Khodor,et al.  Effects of birth insult and stress at adulthood on in vivo tyrosine hydroxylase and tryptophan hydroxylase activities in rat brain , 2003, Synapse.

[121]  E. Walker,et al.  The stress cascade and schizophrenia: etiology and onset. , 2003, Schizophrenia bulletin.

[122]  Paul Greengard,et al.  Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. , 2002, Archives of general psychiatry.

[123]  Peter B. Jones,et al.  Obstetric complications and schizophrenia: historical and meta-analytic review. , 2002, The American journal of psychiatry.

[124]  S. Lawrie,et al.  Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia , 2001, Biological Psychiatry.

[125]  E. Kuipers,et al.  A cognitive model of the positive symptoms of psychosis , 2001, Psychological Medicine.

[126]  D. Javitt,et al.  Auditory sensory dysfunction in schizophrenia: imprecision or distractibility? , 2000, Archives of General Psychiatry.

[127]  M. Laruelle,et al.  Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia , 2000, Biological Psychiatry.

[128]  R. V. Van Heertum,et al.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[129]  D. Dluzen,et al.  Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats , 2000, Brain Research.

[130]  M. Barrot,et al.  The dopaminergic hyper‐responsiveness of the shell of the nucleus accumbens is hormone‐dependent , 2000, The European journal of neuroscience.

[131]  Sophia Frangou,et al.  Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications , 1999, Biological Psychiatry.

[132]  M. Laruelle,et al.  Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.

[133]  M. Laruelle,et al.  Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies , 1999, Journal of psychopharmacology.

[134]  J. Lieberman,et al.  Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. , 1999, The American journal of psychiatry.

[135]  P. Greengard,et al.  Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice , 1999, The European journal of neuroscience.

[136]  Paul Greengard,et al.  DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission , 1998 .

[137]  M. Nader,et al.  Effect of social status on striatal dopamine D2 receptor binding characteristics in cynomolgus monkeys assessed with positron emission tomography , 1998, Synapse.

[138]  B. El-Khodor,et al.  Long-Term Reciprocal Changes in Dopamine Levels in Prefrontal Cortex versus Nucleus Accumbens in Rats Born by Caesarean Section Compared to Vaginal Birth , 1997, Experimental Neurology.

[139]  A. Gratton,et al.  Influence of perinatal factors on the nucleus accumbens dopamine response to repeated stress during adulthood: an electrochemical study in the rat , 1997, Neuroscience.

[140]  K. Miczek,et al.  Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study , 1996, Brain Research.

[141]  P. Kalivas,et al.  Sensitization to Stress and Psychostimulants , 1995 .

[142]  Alan C. Evans,et al.  Elevated dopa decarboxylase activity in living brain of patients with psychosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[143]  M Marmot,et al.  Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort , 1994, The Lancet.

[144]  S. Yoon,et al.  Isolation of two E-box binding factors that interact with the rat tyrosine hydroxylase enhancer. , 1994, The Journal of biological chemistry.

[145]  R. Murray,et al.  The Genetics of Schizophrenia is the Genetics of Neurodevelopment , 1991, British Journal of Psychiatry.

[146]  E. Abercrombie,et al.  Differential Effect of Stress on In Vivo Dopamine Release in Striatum, Nucleus Accumbens, and Medial Frontal Cortex , 1989, Journal of neurochemistry.

[147]  R. Murray,et al.  Is schizophrenia a neurodevelopmental disorder? , 1987, British medical journal.

[148]  D. Weinberger.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1987, Archives of general psychiatry.